• LOGIN
  • SUBSCRIBE
  • FREE E-Newsletter/Product Bulletins

Cath Lab Digest

  • Follow us on
  • Home
  • About Us
    • Privacy Policy/Copyright
    • About VDM
  • Issues
    • Current Issue
    • Issue Archives
  • Editor's Update
  • Advertise
  • Reprints
  • Authors
    • Author Instructions
    • Submission Portal
  • Reviewers
  • Contact

Search

Pedal Artery Access: Advances in Management of Critical limb ischemia

  • Wed, 12/28/11 - 12:38pm
  • 776 reads
  • 0 comments

Critical limb ischemia (CLI) management has been dominated by endovascular advances in the last century. These advances include mostly below knee interventions, use of low profile balloons, crossing devices, and reentry devices. The latest paradigm change in preventing amputation in CLI patients is utilization of pedal artery access. Pedal artery access of the tibioperoneal vessels and combination access along with femoral artery have maximized recanulation rates. Pedal artery access requires knowledge of access via duplex ultrasound and a plan for access management. Advances in pedal artery access include use of dual artery access to maximize angiosome-based interventions. Critical limb ischemia operators should become familiar with this novel technique so that revascularization attempts in CLI patients are maximized.

image description image description
Opinions expressed by authors, contributors, and advertisers are their own and not necessarily those of HMP Communications, the editorial staff, or any member of the editorial advisory board. HMP Communications is not responsible for accuracy of dosages given in articles printed herein. The appearance of advertisements in this journal is not a warranty, endorsement or approval of the products or services advertised or of their effectiveness, quality or safety. HMP Communications disclaims responsibility for any injury to persons or property resulting from any ideas or products referred to in the articles or advertisements.


Post new comment

  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

More information about formatting options

Image CAPTCHA
Enter the characters shown in the image.

  • Advertise your Job Here
    For information on posting classified ads, please contact:
    Alex Dulnikowski, Classified Sales Manager
    (800) 237-7285, ext. 205

vdm Blogs

When Will U.S. See New Lower Limb Devices?

Lawrence A. Garcia MD

Bridge To Nowhere

John E. Lassetter MD FACC FSCAI

PROTECT carotid stent trial provides further evidence that CAS is getting better and becoming more competitive with CEA

Frank J Criado MD FACS FSVM

A New Algorithm to Treat Patients with Peripheral Vascular Disease

Robert S. Dieter MD RVT and Aravinda Nanjundappa MD RVT

In-Stent Restenosis in the SFA Remains a Significant Unresolved Problem

Frank J Criado MD FACS FSVM
more »

Vascular Newswire

  • Medtronic Resolute Integrity Drug-Eluting Stent Obtains FDA Approval for Treating Coronary Artery Disease
    Tue, 02/21/12 - 2:25pm
  • Promising new compound for treating stroke
    Tue, 02/21/12 - 9:13am
  • HHS Announces Intent to Delay ICD-10 Compliance Date
    Fri, 02/17/12 - 2:27pm
  • Aptus Endosystems Initiates the ANCHOR Post-Market Registry
    Tue, 02/14/12 - 2:16pm
more »

Clinical Events Calendar

  • Chronic Total Occlusion Summit
    Thu, 02/23/2012 - Sat, 02/25/2012
    New York, NY, United States
  • NCVH Latin America
    Wed, 02/29/2012 - Fri, 03/02/2012
    San Jose, Costa Rica
  • Interventional Cardiology 2012: 27th Annual International Symposium
    Sun, 03/04/2012 - Fri, 03/09/2012
    Snowmass Village, CO, United States
more »

Poll

How do you feel about the continued practice of screening patients for asymptomatic CAD?:
REVIEW OUR OTHER Cardiology BRANDS

Our other resources for healthcare professionals.

HMP Communications © 2012 HMP Communications

HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC. ©2012 HMP Communications